Moneycontrol PRO

you are here: HomeNewsBusinessCompaniesUS FDA issues shouldn't be overbearing factor for pharma: Citi

SHOW NAMES

Trending Topics

business

US FDA issues shouldn't be overbearing factor for pharma: Citi

Executives of Dr Reddy's Laboratories and Citi tell CNBC-TV18 that the second half of 2016 should be a good one for pharma industry.

first published: Jun 7, 2016 10:57 am

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347